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DOI: 10.1039/c1ay05385jIn this paper, we illustrate the potential of ultra-high performance liquid chromatography (UHPLC)
coupled with hybrid quadrupole time-of-flight mass spectrometry (QTOFMS) for large scale screening
of organic contaminants in different types of samples. Thanks to the full-spectrum acquisition at
satisfactory sensitivity, it is feasible to apply both (post)-target and non-target approaches for the rapid
qualitative screening of organic pollutants in food, biological and environmental samples. Different
strategies have been applied and compared in this work. The first approach consists of target screening
based on automatically extracting the exact analyte masses with a narrow mass window (10 mDa).
The selection of analytes can be made after MS acquisition as non-specific analyte information is
required when injecting the samples. The second, non-targeted approach, consists of a first component
detection step followed by the search of the detected components in home-made spectral libraries. In
this work, two types of libraries have been evaluated: a theoretical database, including the molecular
formula of a large number of pollutants (1000), and an empirical mass spectra library which includes
a lower number of compounds for which reference standards were available. In all cases the confidence
of the identification process was excellent, thanks to the value of information given in QTOF MSE
acquisition mode (i.e. simultaneous acquisition of low and high energy TOF MS spectra in a unique
run). Both, target and non-target approaches, are complementary and both have advantages and
drawbacks. Their application to different types of samples has allowed the detection of diverse organic
compounds, for example the mycotoxin fumonisin B1 in food samples, cocaine and several metabolites
in human urine, as well as several pesticides, antibiotics and drugs of abuse in urban wastewater.Introduction
Nowadays, liquid chromatography (LC) hyphenated to mass
spectrometry (MS) using a variety of mass analyzers is the
technique of choice for the investigation of organic contaminants
in most analyte/sample matrix combinations in environmental,
food or toxicology fields. Mass analyzers used include triple
quadrupole (QqQ),1–6 time-of-flight (TOF), hybrid quadrupole
time-of-flight (QTOF),2,7–11 quadrupole-linear ion trap
(QLIT)3,12,13 or Orbitrap.14 Many examples can be found in the
literature dealing with pesticide residue analysis in environ-
mental,15 food16,17 or biological samples,18 using LC-MS based
methods. Emerging contaminants, such as pharmaceuticals1,5 or
drugs of abuse,19 amongst others, are increasingly being moni-
tored in the environment by LC-MS because their medium-to-
high polarity and low volatility make their determination fitResearch Institute for Pesticide and Water, University Jaume I, Av. Sos
Baynat S/N, 12071 Castellon, Spain. E-mail: felix.hernandez@qfa.uji.es;
Fax: +34 964387368; Tel: +34 964387366
† Electronic supplementary information (ESI) available. See DOI:
10.1039/c1ay05385j
196 | Anal. Methods, 2012, 4, 196–209better with LC. Similarly this applies to metabolites and trans-
formation products, which are generally more polar than their
parent molecules.
LC-tandem MS (LC-MS/MS) operating in Selected Reaction
Monitoring mode (SRM) with QqQ analysers are the work-
horses nowadays in target analysis.20 LC-MS/MS methods rarely
include more than two hundred analytes,2,21,22 and with a few
exceptions,23 most of them are focused on a single family of
contaminants. Excellent sensitivity and notable selectivity are
achieved by LC tandemMS, allowing reliable quantification and
identification of a considerable number of compounds. However,
the presence of other contaminants that might be present in the
samples would be ignored in LC-MS/MS under SRM mode (the
most common approach), due to the analyte-specific information
acquired. There is a need in the field of public health to develop
reliable methods for large-scale screening that are capable of
detecting and identifying a large number of hazardous
compounds that can potentially be present in environmental and
food samples. For this purpose, full spectrum acquisition tech-
niques capable of providing accurate mass measurements are
a great help.This journal is ª The Royal Society of Chemistry 2012
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View Article OnlineTo solve the limitations of unit resolution mass spectrometers,
two main alternatives, based on the use of high-resolution MS
instruments, are of note at present: the time-of-flight24 and
Orbitrap25,26 analysers. Both provide full spectrum accurate-
mass data at satisfactory sensitivity. These capabilities are very
helpful for detecting and identifying not only priority known
pollutants but many other unknown contaminants that might be
a risk for human health.27–29
Although quantitative applications have been reported using
LC-TOF MS or LC-QTOF MS,8,10,30 quantification does not
seem to be the most attractive feature of these analysers. This
may be due to the higher limits of detection and narrower linear
dynamic range in comparison to QqQ analysers. One of the most
interesting applications of TOF MS deals with the wide-scope
screening of a large number of contaminants and residues in
different types of samples, as that allows a significant amount of
useful information on ionisable compounds present in the sample
to be obtained.31 Generic (universal) sample treatments and
chromatographic separations are required to broaden the scope
of the method to as many compounds as possible. Besides, the
elevated acquisition speed of TOF makes it compatible with
ultra-high pressure (Ultra-Performance) liquid chromatography
(UHPLC/UPLC). This technique provides fast, high-
resolution separations that will hopefully minimize matrix effects
and render high mass spectra purity, improving the screening
process.
Different strategies can be used to extract analytical infor-
mation from full-acquisition accurate mass data. A genuine non-
target analysis involves the automated component detection
from the total ion chromatogram (TIC) and the mass spectra
deconvolution for a subsequent comparison with mass spectral
libraries. Nevertheless, electrospray ionization (ESI) is not an ion
source as stable and reproducible as electron ionization,32 and
commercial, standardized ESI mass spectra library are not
available. Instead, theoretical mass spectra libraries, based on the
molecular formula database, can be built which facilitate
increasing the number of compounds that can be searched. These
use accurate mass measurements and isotopic pattern informa-
tion for identification. Home-made empirical libraries can also
be used, but these normally include much fewer compounds due
to the need to inject standards. These experimental libraries offer
fragmentation and retention time information as well, providing
more confidence in the compound identification process.33
However, the possibility of detecting and identifying the sample
contaminants, using both mass spectra libraries in a non-target
analysis, depends on the success of the deconvolution process, i.e.
the capability of the software to find the component peaks and to
obtain mass spectra as free as possible of sample interferents.
Obviously, the more complex the matrix, the more difficult the
deconvolution will be.
An efficient approach to overcome the component detection
limitations is the use of ‘‘post-target’’ methodology,34,35 i.e. the
selection of the analytes to be searched is done after MS acqui-
sition. A post-target screening facilitates the detection of the
compounds as it is only focussed on those pollutants selected. It
is unnecessary to totally deconvolute all components present in
the samples, these mainly belong to matrix compounds.
Furthermore, processing and reviewing steps become easier as
fewer compounds are searched for and consequently detected.This journal is ª The Royal Society of Chemistry 2012In this work three sample types have been selected (waste-
water, food and human urine) to explore the potential of
UHPLC-(Q)TOF MS to detect and identify/elucidate organic
contaminants and/or residues. Two strategies have been applied
for this purpose: a post-target screening, based on mass filtering
at the exact mass of the compound investigated (typically the (de)
protonated molecule) using narrow mass extraction windows
and a non-target methodology using both empirical and theo-
retical mass spectra libraries. QTOF MS has been used under
MSE mode, i.e. simultaneous acquisition at low (LE) and high
collision energy (HE) functions, which provides useful informa-
tion on the (de)protonated molecules (commonly at LE) and on
the main fragments ions (commonly in HE). On the basis of this
information, and on isotopic distribution observed in the spectra,
the reliable identification of the compounds detected in the
samples was feasible.
Experimental
Reagents and chemicals
HPLC-grade water was obtained from deionized water passed
through a Milli-Q water purification system (Millipore, Bedford,
MA, USA). HPLC-grade methanol (MeOH) and acetonitrile
(ACN) were purchased from ScharLab (Barcelona, Spain).
Formic acid (HCOOH) (>98%) was obtained from Fluka
(Buchs, Switzerland). Sodium hydroxide (>99%) was obtained
from ScharLab. Leucine enkephalin, used as lock mass, was
purchased from Sigma Aldrich (St Louis, MO, USA).
Reference compounds were purchased from Acros Organics
(Geel, Belgium), Bayer Hispania (Barcelona, Spain), Fort Dodge
Veterinaria (Gerona, Spain), Vetoquinol Industrial (Madrid,
Spain), Aventis Pharma (Madrid, Spain), Sigma Aldrich (St
Louis, MO, USA), Cerilliant (Round Rock, TX, USA), Dr
Ehrenstorfer (Augsburg, Germany), Riedel-de Ha€en (Seelze,
Germany), the National Measurement Institute (Pymble, Aus-
tralia) and Fluka. All reference materials presented purity higher
than 93% (w/w).
Instrumentation
An UPLC Acquity system coupled with a hybrid quadrupole
orthogonal acceleration-time-of-flight (Q-oaTOF) mass spec-
trometer (QTOF Premier, Waters, Milford, MA) provided with
an orthogonal Z-spray lockspray electrospray interface (ESI)
was used.
Mobile phases A and B were water and methanol respectively,
both with 0.01% formic acid. The separation was performed on
an Acquity C18 BEH analytical column (150 mm  2.1 mm, i.d.
1.7 mm) at a flow rate of 0.3 mL min1 (at 60 C). The initial
percentage of methanol was 10%, which was linearly increased to
90% in 14 min, followed by a 2 min isocratic period and, then,
returned to initial conditions during 2 min in total run duration
of 18 min. The injection volume was 50 mL.
Cone and nebulizer gas were nitrogen (Praxair, Valencia,
Spain) at flow rates of 60 L h1 and 600 L h1, respectively. The
nitrogen desolvation temperature was set to 350 C and the
source temperature to 120 C. A cone voltage of 25 V and
capillary voltages of 3.5 kV and 2.5 kV in positive and negative
ionisation modes, respectively, were used.Anal. Methods, 2012, 4, 196–209 | 197
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View Article OnlineTOF MS resolution was 10 000 at full width half maximum
(FWHM) in V-mode. MS spectra were acquired over an m/z
range 50–1000. Collision gas was argon 99.995% (Praxair,
Valencia, Spain), which was always turned on with a pressure of
approximately 5  103 mbar.
Two acquisition functions were created with different collision
energies. The first one, the low energy (LE) function, at low
collision energy (4 eV) and the second one, the high energy (HE)
function, with a collision energy ramp ranging from 15 to 40 eV.
The scan time values of LE and HE functions were set to 0.2 and
0.15 s, respectively, both with an inter-scan delay of 0.05 s.
The lock mass (leucine enkephalin, 2 mg L1 in ACN : water,
50 : 50) was introduced via the lock spray needle at a flow rate of
30 mL min1 using a reagent manager pump (Waters). A cone
voltage of 60–70 V was selected and checked daily to obtain
adequate signal intensity for this compound (around 500 counts).
Calibration of the m/z-axis was performed using the built-in
single-syringe pump, directly connected to the interface. Cali-
bration from 50 to 1000 m/z was conducted with a 1 : 1 mixture
of 0.05 M NaOH : 5% HCOOH diluted (1 : 25) with water/ACN
(20 : 80 v/v) plus imazalil (m/z 297.0561) at a final concentration
of 500 mg L1.
Data station operating software was MassLynx v 4.1. Chro-
maLynx XS application manager was used for non-target
(deconvolution and library search) as well as for target analysis.Sample treatment
8 wastewater samples—4 influent (IWW) and 4 effluent
(EWW)—10 human urine and 6 food samples (2 oranges, 2
banana and 2 corn samples) were analysed for comparing the
screening approaches.
50 mL of wastewater were pre-concentrated by off-line SPE
using 200 mg Oasis HLB cartridges, eluted with 5 mL of MeOH,
evaporated under a gentle nitrogen stream at 40 C and recon-
structed with 1 mL water : MeOH (90 : 10 v/v).
Food sample extraction was performed according to previous
work developed by our group.6,36 20 g of triturated and
homogenized orange or banana samples were extracted with
60 mL water : MeOH (20 : 80 v/v) for 2 min using a high-speed
blender, filtered and diluted with water : MeOH (20 : 80 v/v) to
a final volume of 100 mL. Afterwards, an aliquot of the extract
was diluted eightfold with water.
2.5 g of crushed corn sample were extracted with 10 mL
ACN : water (80 : 20 v/v) with 0.1% HCOOH and mechanically
shaken for 90 min.6 Afterwards, the solution was centrifuged,
and a 5 mL aliquot of supernatant was diluted twofold with
water.
Human urine samples from healthy volunteers and from
people involved in drug detoxification programmes were centri-
fuged, diluted fivefold with water and directly injected into the
LC-QTOF instrument.Software parameters
The deconvolution and spectra rejection parameters were
selected as follows:
 minimum peak width at 5% height: 4 s,
 peak-to-peak baseline noise: 5,198 | Anal. Methods, 2012, 4, 196–209 smoothing activated,
 mass tolerance (mass window width): 20 mDa,
 two mass chromatograms extracted for each component in
LE function (5 mass chromatograms for HE), i.e. 2 or 5 coeluting
ions to be extracted with the narrow window mass selected
(10 mDa).
The values for minimum peak width and mass window were
selected as a function of the chromatographic resolution and
mass accuracy data of our instrument.
Accurate mass scoring parameters were selected as follows:
 Number of ions used for accurate mass scoring: 2
 Minimum intensity (% of largest peak in the range): 10
 High precision mass tolerance (colouring in green): 2.5 mDa
 Low precision mass tolerance (colouring in yellow) ¼ 5 mDa
These values were selected according to our own experience
and characteristics of the LC-QTOF MS equipment used, but
they might be modified according to the performance of the
instrument used in each laboratory.Results and discussion
Mass resolving power is an important issue for the correct
detection and identification of the suspect compounds. Even if
the 10 000 at 10% valley resolution (20 000 FWHM) required by
the EC Decision 2002 (ref. 37) is not achieved by the (Q)TOF
mass spectrometer used, we consider that mass accuracy is really
the key in the identification of the compounds in the wide-scope
screening. Although strongly correlated, mass resolving power
and mass accuracy are not strictly the same. In a previous work,33
improving the resolution (about 18 000 FWHM) by doubling the
path length using the so-called W-mode in different matrices
(influent and effluent wastewater, surface water, pepper and
cucumber) showed no significant effect for the compounds tested
on mass accuracy achieved using UHPLC separation. On the
other hand, a 20 mDa mass window has been used in this work
for both, non-target and post-target strategies, as a compromise
between ensuring correct chromatographic peak at both ends
and attainable selectivity. Lower mass windows (e.g. 5 and
10 mDa) were also tested, but finally discarded as no satisfactory
chromatographic peaks were always ensured. Newer instruments
with stable mass accuracy across the peak could facilitate the
screening process by reducing this mass window, even down to
1 mDa.
The non-target and post-target strategies studied in this work
were applied to all selected samples to test the screening capa-
bilities and for comparison purposes. A flowchart of the process
is shown in Fig. 1.1. Non-target screening
A true non-target screening using LC-(Q)TOF MS is a chal-
lenging task as it is very difficult to detect and identify trace level
contaminants when no selection is made on the compounds to be
searched.38 In this work, non-target screening was applied to
environmental, food and biological samples to evaluate the
potential of the algorithm to detect components when dealing
with complex matrices. For this purpose, the deconvolution
software ChromaLynx XS in a non-target mode was used. The
software applies a component detection algorithm (CODA) toThis journal is ª The Royal Society of Chemistry 2012
Fig. 1 Flowchart of the overall screening process.
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View Article Onlinedeconvolute the TIC and detect the components present in the
sample. Afterwards, it compares the spectra assigned to every
component with those included in the home-made libraries. To
facilitate the confirmation of the identity of the components
detected, two functions were simultaneously acquired at different
collision energies (MSE). The LE function was used to obtain the
(de)protonated molecules (occasionally adducts and fragment
ions). The HE function was used to promote fragmentation,
improving the identification of the positive findings as spectra
obtained were quite similar to those of MS/MS experiments.33,39
This acquisition provides reproducible spectra without the need
of precursor ion pre-selection in the first quadrupole. The success
for detecting and identifying non-target compounds using this
approach obviously depends on the deconvolution process. In
addition, MSE provides not only fragmentation spectra but also
isotopic pattern information of the fragments and it conserves
adduct and/or dimer information. However, two main limita-
tions were noticed when MSE was applied to non-target
screening:
(a) As there is no pre-selection of precursor ion in the quad-
rupole, the MSE approach is less specific and might be conflictive
when dealing with non-selective fragments in the presence of
co-eluting related compounds. This occurs, for example, whenThis journal is ª The Royal Society of Chemistry 2012investigating amphetamine-like compounds amphetamine and
methamphetamine. As can be seen in Fig. 2, both drugs elute at
very close retention times and present poor and identical HE
spectra, with the most abundant ion being the non-selective
fragment atm/z 91 corresponding to tropylium ion. Moreover, as
protonated molecules have relatively poor abundance in the LE
function (especially amphetamine) it could be very difficult to
distinguish both compounds at low concentration levels.
(b) The success of the MSE approach can be limited by the
quality of the spectrum.39 Thus, low sensitivity or strongly
interfered spectra end up making it unfeasible to match with
library spectra as well as not being able to elucidate the
component using fragment interpretation. In these cases, addi-
tional MS/MS experiments would be helpful in the identification/
elucidation process.
Finally, the software returns a match factor for the compar-
ison of standard and candidate mass spectra and gives the mass
errors for the 2 most abundant ions present in the LE function
and for the 5 main fragment ions present in the HE function. A
positive match can be filtered by a minimum match factor and
retention time, if available. In this work, a relatively low match
factor (in reverse fit) of 70% was selected as a compromise. This
facilitated the reviewing process of positives without losingAnal. Methods, 2012, 4, 196–209 | 199
Fig. 2 LE and HE mass spectra for amphetamine-like compounds. LE
spectra for methamphetamine and amphetamine show notable in-source
fragmentation with different [M + H]+ ion (m/z 150.1290 and 136.1134).
Identical HE spectra (m/z 91.0548 corresponding to tropylium ion) are
obtained for both compounds.
Fig. 3 ChromaLynx XS browser with accurate mass confirmation for Fu
compound with mass error <2.5 mDa (which offers retention time, area, ma
20 mDa window). (c) mass spectrum (in blue, candidate peak is shown).
200 | Anal. Methods, 2012, 4, 196–209
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View Article Onlinepotential hazardous compounds that could be present in the
samples although with low match factors. Two types of mass
spectra libraries were evaluated in this work as discussed in the
following sections.
When no or unsatisfactory match is obtained, the components
appear to be tentative. In these cases, the elucidation of the
compound requires a lot of time and effort with a low possibility
of success. Furthermore, the majority of non-matched compo-
nents are likely to be matrix compounds.
1.1 Theoretical library. Initially, a database containing
approximately one thousand pollutants of different families
(pesticides, antibiotics, pharmaceuticals, illicit drugs, myco-
toxins, anabolic steroids, personal care products and metabo-
lites) was built (see ESI†). The compounds were included based
on our own experience on LC-MS/MS analysis of environmental
and food samples, and on bibliographic data on LC-MS
amenable organic pollutants. The database was created sepa-
rating positive and negative ionisable compounds. It contained
information on the molecular formula (required by the software),
exact mass of the neutral and the (de)protonated molecule, as
well as supplementary information† of the compound type and
on retention time, when available. From the molecular formulae
of each compound, two theoretical mass spectra libraries (for
positive and negative ionisation modes) were automatically built,
containing theoretical nominal mass spectra of the (de)proton-
ated molecule and sodium adducts as well as the theoretical
isotopic pattern expected for each compound. Each librarymonisin B1 in corn using post-target screening. (a) Candidate list for
ss error and i-FIT information), (b) nw-XIC for suspected candidate (at
This journal is ª The Royal Society of Chemistry 2012
Table 1 Results of different screening approaches for representative samples. Common data for all approaches are shown: retention time (RT),
retention time deviation (only when available) and mass error. For target screening, confirmation withMSE was performed when reference standard was
previously injected. Detection of sodium adduct and/or fragment ions in the LE function is reported. Reverse Fit is given for compounds detected by
non-target approaches
Effluent wastewater
Target screening Non-target screening
Tentative
identification
Confirmed with
standard?
LE function Theoretical
library
Empirical
library
Compound
RT
(min)
DRT
(%)
Dmass/
mDa Strategy 1a Strategy 2b
Na
adduct?
Fragment
ions?
Match
reverse fit
Match
reverse fit
Antipyrine 5.43 — 1.4 —
Bamethan 3.43 — 0.5 3  —
Bisoprolol 7.25 — 0.0 3 3 — 929
Caffeine 4.19 — 0.2 3 3 —
Carbendazim 4.45 0.04 0.5 Yes 3(1) 923 898
Celiprolol 6.41 — 0.7 3 3 —
Clarithromycin 10.11 0.10 1.7 Yes 855
Clofibric acid 12.60 — 2.5 3  —
Codeine 2.82 0.00 1.6 Yes 943 794
Diazinon 13.04 0.01 0.9 Yes
Diuron 9.98 0.02 0.3 Yes
Erithromycin
(H2O)
9.86 0.01 1.2 Yes
Gabapentin 3.47 0.09 0.5 3 3 Yes 3(2) 903
Irbesartan 11.42 0.10 0.0 3 3 Yes 953
Ketoprofen 10.61 0.04 0.5 Yes 3
Metoprolol 5.55 — 0.0 3 3 —
Nordiazepam 11.01 — 0.1 3 —
OD-PABA 5.49 — 0.9 3 3 — 953
Oxazepam 10.19 — 0.4 3 —
Oxprenolol 2.77 — 0.2 3 3 —
Propylphenazone 9.29 — 0.4 3 3 —
Terbutryn 11.69 0.14 1.0 Yes
Thiabendazol 5.22 0.12 0.1 Yes
Trimethoprim 3.83 0.10 0.9 Yes 980 925
Valsartan 11.59 0.05 1.9 3 3 Yes 3 849
Venlafaxine 7.17 0.46 0.3 Yes 3(1)
MDMA 3.78 0.00 0.0 Yes 3(2)
Bezafibrate* 11.07 0.01 2.1 Yes 3
Gemfibrozil* 13.84 0.03 2.5 Yes 3
*Compounds found only as sodium adduct ion
Orange
Target screening Non-target screening
Tentative
identification
Confirmed with
standard?
LE function Theoretical
library
Empirical
library
Compound
RT
(min)
DRT
(%)
Dmass/
mDa Strategy 1a Strategy 2b
Na
adduct?
Fragment
ions?
Match
reverse fit
Match
reverse fit
Imazalil 9.22 0.03 0.3 Yes 916 925
Thiabendazol 5.21 0.03 0.3 Yes 893 916
Banana peel
Target screening Non-target screening
Tentative
identification
Confirmed with
standard?
LE function Theoretical
library
Empirical
library
Compound
RT
(min)
DRT
(%)
Dmass/
mDa
Strategy
1ab Strategy 2b
Na
adduct?
Fragment
ions?
Match
reverse fit
Match
reverse fit
Chlorpyrifos 14.61 0.01 0.5 Yes 3
Diazinon 13.03 0.01 0.7 Yes 854 863
Imazalil 9.21 0.02 0.9 Yes 931 923
This journal is ª The Royal Society of Chemistry 2012 Anal. Methods, 2012, 4, 196–209 | 201
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Table 1 (Contd.)
Corn
Target screening Non-target screening
Tentative
identification
Confirmed with
standard?
LE function Theoretical
library
Empirical
library
Compound
RT
(min)
DRT
(%)
Dmass/
mDa
Strategy
1ab Strategy 2b
Na
adduct?
Fragment
ions?
Match
reverse fit
Match
reverse fit
Fumonisin B1 10.10 0.03 0.8 Yes 785 800
Fumonisin B2 11.69 0.03 1.2 Yes 681 686
Fumonisin B3 10.97 — 1.3 3 3 —
Fumonisin B4 12.44 — 0.2 3 3 —
Urine sample
Target screening Non-target screening
Tentative
identification
Confirmed with
standard?
LE function Theoretical
library
Empirical
library
Compound
RT
(min)
DRT
(%)
Dmass/
mDa
Strategy
1ab Strategy 2b
Na
adduct?
Fragment
ions?
Match
reverse fit
Match
reverse fit
Gabapentin 3.27 0.05 0.8 Yes (2) 893
Nicotine 2.72 — 1.1 3 3 —
Paracetamol 2.68 0.02 0.3 Yes
Risperidone 6.72 0.10 0.0 Yes
Amphetamine 3.27 0.20 0.4 Yes (2) 874
Benzoylecgonine 5.04 0.02 1.0 Yes 895 967
Cocaethylene 6.25 0.11 0.4 Yes
Cocaine 5.16 0.19 0.8 Yes 716
NorBenzoylecgonine 5.28 0.00 0.6 Yes
NorCocaethylene 5.71 — 0.7 3 3 —
NorCocaine 5.34 0.05 0.2 3 3 —
a Strategy 1, used for tentative identification of the compounds when the standard was not available, consisted of comparing the main fragments
observed in the HE function with common MS/MS product ions reported in the literature. b Strategy 2 was made by justifying the HE accurate
mass fragments using a bond-disconnecting software.
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View Article Online(positive and negative modes) was used in the corresponding
acquisition mode.
A drawback of the theoretical library (and also of the empir-
ical mass spectra library) is that TOF MS spectra are stored in
nominal mass for NIST format compatibility, and in this step the
mass accuracy information given by TOF MS is lost. In order to
minimize this limitation, the mass errors between the measured
masses of the compound detected and the exact masses of the
candidates formulae are calculated and used in a subsequent
step, to rank them and to propose the most plausible identity
(accurate mass scoring).35
1.2 Empirical library. Details about reference standards
injected and conditions for the creation of the empirical spectra
library are reported in Dıaz et al.33 Briefly, around 230 reference
standards of selected contaminants were injected in both, posi-
tive and negative, ionisation modes at low and high collision
energy (MSE mode) to obtain retention time and fragmentation
information under the previously optimized conditions.33 For
each compound, two library entries (LE and HE spectra) were
created including name, exact mass, retention time and spectra.
Detection/identification problems derived from LE adducts
formation and/or important in-source fragmentation were pre-
vented by analyzing the samples under exactly the same condi-
tions as the reference standards. This favoured the task and
minimized the risk of potential false negatives. Furthermore, HE
mass spectra were automatically matched with those included in
the empirical library which greatly facilitated the confirmation of202 | Anal. Methods, 2012, 4, 196–209the compound identity. In our experience, HE provided highly
reproducible spectra (independently of the type of sample ana-
lysed) when the component was found at relatively high abun-
dance. As signal intensity is the main limitation during the
component detection step, HE spectra facilitated identification of
the compound when its spectrum was available in the library in
those components detected by the non-target approach.2. Post-target screening
Trying to avoid the dependence of the screening success on the
component detection algorithm, a post-target screening strategy
was applied including an extraordinarily large number of
compounds in the search. The term ‘‘post-target’’ was first used
by our group34,35,40 as a target screening without pre-selection of
the analytes before analysis. It consists of searching for a list of
target compounds after MS full-acquisition. Other authors name
this approach, when reference standards are unavailable, as
suspect screening.20 In the post-target screening, a database with
the same compounds included in the theoretical library of the
non-target approach was used (ESI†). ChromaLynx XS uses the
molecular formula to calculate the exact mass for [M + H]+.
Then, the software automatically performs the extraction of
a nw-XIC (20 mDa) for each compound in the LE and HE
functions and looks for peaks (S/N and peak width higher than
pre-selected values) in the corresponding chromatogram. A list
of potential candidates found in the sample is shown in different
colours depending on accurate mass measurement; positiveThis journal is ª The Royal Society of Chemistry 2012
Table 2 Illustrative example of the database used in the post-target approach. Database entries were created including molecular formula, retention
time (when available), accurate mass and pollutant family, as well as bibliographic source when data were not empirically obtained by reference standard
injection. Different entries were created for sodium adducts (marked as Na) and in-source fragments (marked as F1, F2, etc.). Entries marked with (*)
indicate the main ion/s in the reference standard spectrum
Compound Molecular formula Rt (min) Ion type Accurate mass Pollutant family Source
Oxytetracycline* C22H24N2O9 4.83 [M + H]
+ 461.1560 Antibiotic
Oxytetracycline F1 C22H22N2O8 4.83 Fragment ion 443.1454 Antibiotic
Oxytetracycline F2 C22H19NO8 4.83 Fragment ion 426.1189 Antibiotic
Amphetamine C9H13N 3.06 [M + H]
+ 136.1126 Illicit drug
Amphetamine F1 C9H10 3.06 Fragment ion 119.0861 Illicit drug
Amphetamine F2* C7H6 3.06 Fragment ion 91.0548 Illicit drug
MDMA C11H15NO2 3.14 [M + H]
+ 194.1181 Illicit drug
MDMA F1* C10H10O2 3.14 Fragment ion 163.0759 Illicit drug
MDMA F2 C8H6O2 3.14 Fragment ion 135.0446 Illicit drug
6-OH-4-Cl-dehydromethyltestosterone C20H27O3Cl 9.91 [M + H]
+ 351.1727 Steroid
6-OH-4-Cl-dehydromethyltestosterone
(–H2O)
C20H25O2Cl 9.91 Fragment ion 333.1621 Steroid
6-OH-4-Cl-dehydromethyltestosterone
(2  H2O)
C20H23OCl 9.91 Fragment ion 315.1515 Steroid
6-OH-4-Cl-dehydromethyltestosterone
(Na)*
C20H26NaO3Cl 9.91 [M + Na]
+ 373.1547 Steroid
Ethisterone C21H28O2 — [M + H]
+ 313.2168 Steroid JMS,42,2007,497-516
Ethisterone [M + Na + MeOH]+ C22H31NaO3 — [M + Na + MeOH]
+ 367.2249 Steroid JMS,42,2007,497-516
Fumonisin B1* C34H59NO15 10.13 [M + H]
+ 722.3963 Mycotoxin
Fumonisin B2* C34H59NO14 11.66 [M + H]
+ 706.4014 Mycotoxin
Aldicarb sulfoxide C7H14N2O3S 3.19 [M + H]
+ 207.0803 Pesticide
Aldicarb sulfoxide (Na)* C7H13NaN2O3S 3.19 [M + Na]
+ 229.0623 Pesticide
Aldicarb sulfoxide F1* C4H8S 3.19 Fragment ion 89.0351 Pesticide
Aldicarb sulfoxide F2 C5H9NOS 3.19 Fragment ion 132.0483 Pesticide
Tebufenozide C22H28N2O2 12.54 [M + H]
+ 353.2229 Pesticide
Tebufenozide (Na)* C22H27N2O2Na 12.54 [M + Na]
+ 375.2048 Pesticide
Tebufenozide (2M + Na)* C44H55N4O4Na 12.54 [2M + Na]
+ 727.4199 Pesticide
Tebufenozide F1* C18H20N2O2 12.54 Fragment ion 297.1603 Pesticide
Tebufenozide F2* C9H8O 12.54 Fragment ion 133.0653 Pesticide
Azinphos-methyl C10H12N3O3PS2 10.49 [M + H]
+ 318.0136 Pesticide
Azinphos-methyl (Na)* C10H11N3O3PS2Na 10.49 [M + Na]
+ 339.9956 Pesticide
Azinphos-methyl F1 C8H5N3O 10.49 Fragment ion 160.0511 Pesticide
Azinphos-methyl F2* C8H5NO 10.49 Fragment ion 132.0449 Pesticide
Azoxystrobin C22H17N3O5 10.97 [M + H]
+ 404.1246 Pesticide
Azoxystrobin (Na)* C22H16NaN3O5 10.97 [M + Na]
+ 426.1066 Pesticide
Azoxystrobin F1* C21H13N3O4 10.97 Fragment ion 372.0984 Pesticide
Bifenazate C17H20N2O3 11.92 [M + H]
+ 1.0078 Pesticide
Bifenazate (Na)* C17H19N2O3Na 11.92 [M + Na]
+ 22.9898 Pesticide
Bifenazate F1 C13H11NO 11.92 Fragment ion 198.0919 Pesticide
Bifenazate F2 C12H11N 11.92 Fragment ion 170.0970 Pesticide
Dimethoate C5H12NO3PS2 5.76 [M + H]
+ 230.0075 Pesticide
Dimethoate (Na)* C5H11NaNO3PS2 5.76 [M + Na]
+ 251.9895 Pesticide
Methiocarb sulfone C11H15NO4S 6.27 [M + H]
+ 258.0800 Pesticide
Methiocarb sulfone (Na)* C11H14NO4SNa 6.27 [M + Na]
+ 280.0620 Pesticide
Methiocarb sulfone F1 C9H12O3S 6.27 Fragment ion 201.0585 Pesticide
Methiocarb sulfone F2* C8H9O 6.27 Fragment ion 122.0732 Pesticide
Methiocarb sulfoxide C11H15NO3S 5.73 [M + H]
+ 242.0851 Pesticide
Methiocarb sulfoxide (Na) C11H14NO3SNa 5.73 [M + Na]
+ 264.0671 Pesticide
Methiocarb sulfoxide F1* C9H12O2S 5.73 Fragment ion 185.0636 Pesticide
Thiamethoxam C8H10ClN5O3S 4.26 [M + H]
+ 292.0271 Pesticide
Thiamethoxam (Na)* C8H9ClN5O3SNa 4.26 [M + Na]
+ 314.0091 Pesticide
Thiamethoxam F1* C8H10N4OS 4.26 Fragment ion 211.0654 Pesticide
Thiamethoxam F2 C4H2NSCl 4.26 Fragment ion 131.9675 Pesticide
Thiobencarb C12H16ClNOS 13.39 [M + H]
+ 258.0719 Pesticide
Thiobencarb (Na)* C12H15NaClNOS 13.39 [M + Na]
+ 280.0539 Pesticide
Thiobencarb F1* C7H5Cl 13.39 Fragment ion 125.0158 Pesticide
Thiodicarb C10H18N4O4S3 9.36 [M + H]
+ 355.0568 Pesticide
Thiodicarb (Na)* C10H17NaN4O4S3 9.36 [M + Na]
+ 377.0388 Pesticide
Thiodicarb F1 C3H5NS 9.36 Fragment ion 88.0221 Pesticide
Bezafibrate C19H20ClNO4 11.06 [M + H]
+ 362.1159 Pharmaceutical
Bezafibrate (Na)* C19H19NaClNO4 11.06 [M + Na]
+ 384.0979 Pharmaceutical
Chloramphenicol C11H12Cl2N2O5 6.46 [M + H]
+ 323.0201 Pharmaceutical
Chloramphenicol (Na) C11H11NaCl2N2O5 6.46 [M + Na]
+ 345.0021 Pharmaceutical
Chloramphenicol F1* C11H10N2O4Cl2 6.46 Fragment ion 305.0101 Pharmaceutical
Chloramphenicol F2* C10H8N2O3Cl2 6.46 Fragment ion 275.0002 Pharmaceutical
Chloramphenicol F3 C11H8NOCl2 6.46 Fragment ion 241.0078 Pharmaceutical
Gemfibrozil C15H22O3 13.81 [M + H]
+ 251.1647 Pharmaceutical
Gemfibrozil (Na)* C15H21NaO3 13.81 [M + Na]
+ 273.1467 Pharmaceutical
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View Article Online(green) for error <2.5 mDa, tentative (yellow) for error between
2.5 and 10 mDa, and negative (red) for error >10 mDa.
Furthermore, as in the non-target approach, ChromLynx XS
filters positive findings according to retention time deviation
limit when this information is available in the database (reference
standards previously injected). The retention time window was
set in 0.5 min but accepted tolerance was 2.5%. Thus, the
retention times for 231 analytes, injected when building the
empirical library, were also introduced in the database. In this
way, nw-XIC, top peak spectra and mass error as well as isotopic
distribution fit (i-FIT) information, retention time (measured
and expected when already known) and peak area were available
for positive matches. Fig. 3 shows the ChromaLynx XS browser
for a positive of mycotoxin Fumonisin B1 in a corn sample using
this approach.
QTOF MS post-target screening has proved to be an efficient
tool due to the high number of pollutants screened. The potential
of this approach to detect different families of organic contam-
inants, for example drugs of abuse or antibiotics in environ-
mental samples, has been reported recently.39,41 The easy
reviewing step and the relevant information obtained, such as
accurate mass spectrum of the peak, mass error for the proton-
ated molecule and the most abundant fragments, and isotopic
distribution, give high confidence to the confirmation of poten-
tial positives even without reference standards being available.
The large number of contaminants included in the list (more thanFig. 4 Positive finding of the pharmaceutical gabapentin in human urine: (a) o
source fragments at m/z 154 and 137) in the LE function and seven coeluting
standard (c) showing good correlation for up to six abundant fragment ions.
204 | Anal. Methods, 2012, 4, 196–2091000) opens a new scenario in screening, favouring a more
realistic overview when investigating organic contaminants in
different applied fields. However, if only the predicted presence
of the protonated molecule was taken into account in the LE
function, potential in-source fragments would not be detected
(e.g. as occurs in amphetamine-like compounds, see Fig. 2), not
even sodium or other adducts that could be formed.
In this work, formic acid was added to the mobile phases.
Under this situation, ammonia adducts and other adducts like
[M +MeOH + H]+ or [M + K]+ would not normally be expected.
However, sodium adducts are common for many LC-amenable
compounds, and they might be present despite using formic acid.
In our own experience, 88 out of 231 compounds (38%) included
in the experimental library showed sodium adducts at relative
abundance higher than 10%. Among them, 38 compounds (16%
of the total compounds) presented the [M + H]+ ion at relative
intensity lower than 10%, this becoming the [M + Na]+, the most
abundant ion in the mass spectra. When analyzing real samples,
sodium adducts might be found at higher abundance due to the
normal presence of sodium in the sample matrices. Therefore, it
is important to include sodium adducts in the screening to avoid
potential false negatives in those cases where it is the most
abundant ion (see Table 1). However, it seems reasonable not to
include sodium adducts for all analytes investigated, as the
processing and the reviewing step would be much longer and
more tedious. The injection of reference standards and/orverlapped nw-XIC for three main ions (protonated ion atm/z 172 and in-
ions in the HE function. LE and HE spectra for sample (b) and reference
This journal is ª The Royal Society of Chemistry 2012
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View Article Onlineliterature search, along with analyst experience, are necessary
parts of knowing when it is reasonable to include compound
adducts to improve the confidence of the screening process.
A similar problem may occur when important in-source
fragmentation takes place at the LE function. In this work, we
used 25 V cone voltage as better sensitivity was observed for
selected analytes in the 20–30 V range.33 Obviously, this cone
voltage is a compromise value as it is not the best choice for all
compounds but it is impossible to optimize any variable for all
LC-amenable compounds included in the database. As previ-
ously stated, amphetamine ([M + H]+ 136.1126) presents an in-
source fragment at m/z 91.0553 as the most abundant ion in the
spectra, while the protonated molecule has an abundance lower
than 10% (Fig. 2). Other examples are the insecticide carbaryl
(fragment at m/z 145.0563) or pesticide metabolite aldicarb
sulfoxide (fragment at m/z 89.0415). In these cases, analyte
detection in samples based on testing [M+H]+ presence would be
only feasible at relatively high analyte concentrations.
Other compounds, like anabolic steroids, are frequently ion-
ised forming adducts with MeOH, acetonitrile, ammonium or
sodium (as a function of the mobile phase and sample matrix
composition) and/or they suffer in-source fragmentation with
neutral losses of one, or even two, water molecules ([M  H2O +
H]+, [M  2H2O + H]+).42 The later drawback is more difficult to
solve than adducts formation, but it could be circumvented by
including empirical formula of the known fragment ions in the
database. Again, information reported in the literature and/or
from reference standards injection would be required to include
expected fragments in the database. Although fragmentation
behaviour is not completely known in most cases, in ourFig. 5 Positive finding of the pharmaceutical irbesartan in effluent wastewate
justification of the HE fragments usingMassFragment software. (c) nw-XICs (
HE function.
This journal is ª The Royal Society of Chemistry 2012experience, this effect is less common than adduct formation.
Indeed, only 6 out of 231 compounds (3% of the compounds
studied) almost exclusively presented the fragment ion as base
peak, with the protonated ion being practically absent. In these
particular cases, monitoring this fragment is mandatory for
compound detection. In-source fragmentation turns into a useful
confirmatory tool when the reference standard is available and/
or its behaviour is well known. Thus, including most abundant
fragments is always useful for automated confirmation.
As an illustrative example, Table 2 shows information on
database entries for different types of analytes included in this
work. The molecular formula of the ion, when adduct formation
and/or in-source fragmentation occurred, was also introduced in
the database, as well as the bibliographic source, when infor-
mation on possible occurrence of these ions was not directly
obtained from reference standard injection.3. Application to samples
After application of the screening strategies to selected food,
wastewater and human urine samples, the post-target approach
was found to be the most efficient for wide-scope screening. In all
samples analyzed, the number of positives was higher than using
the non-target approach, in this way giving a more realistic
overview of the presence of organic pollutants in the samples. A
summary of the results obtained for selected samples is shown in
Table 1. The list of pollutants found by target and non-target
screening (those with an adequate match reverse fit) is reported
together with the main information managed (mass error and
retention time), as well as retention time deviation whenr. Spectra for LE function (a) and HE function (b) of the suspect peak and
20mDamass window) for [M+H]+ in LE function andmain fragments in
Anal. Methods, 2012, 4, 196–209 | 205
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View Article Onlinereference standard was available. Almost in all cases, Rt devia-
tion was lower than 1%. However, the retention time window for
positive match was 0.5 min due to the wide range of matrix
analysed having, in some particular cases, deviations higher than
2% typically accepted as in the case of Venlafaxin. Confirmation
using MSE is also shown when it could be made. When reference
standards were unavailable, information on fragmentation and
retention time was absent. Two strategies were followed to
improve the confidence in the compound identification.
The first strategy (Strategy 1 in Table 1) was to simply compare
main fragments observed in HE acquisition with commonMS/MS
product ions reported in the literature for the suspect compound.
This was the case for the antibiotic gabapentin, which was detected
and identified in urine and wastewater by the presence of two
abundant fragments in the HE spectrum with m/z 137.0966 and
154.1232 (Fig. 4). These fragment ions were also present in the LE
function and had been reported by other authors for determination
of gabapentin by QqQ.43–45 Elemental composition for these two
fragments was calculated based on their accurate masses obtaining
errors of 0.7 and 0.2 mDa, respectively.
The second strategy (Strategy 2 in Table 1) consisted of justi-
fying the fragments accurate mass (typically observed in the HE
spectra) using MassFragment software. This software applies
a bond-disconnecting methodology to obtain possible structures
for the fragment ions from a given molecule. An example of this
approach is shown in Fig. 5, where identification of main frag-
ments of the pharmaceutical irbesartan was carried out. For thisFig. 6 Positive finding of the drug of abuse MDMA in effluent wastewater. (
in-source fragment at m/z 163) in the LE function, and up to five coeluting io
standard (c) showing good correlation for up to five abundant fragment ions
206 | Anal. Methods, 2012, 4, 196–209purpose, LE and HE combined spectrum of suspect irbesartan
was extracted from the chromatographic peak (Fig. 5a and b).
The main fragments were justified with the MassFragment tool
obtaining reliable structures for all of them. In order to avoid
spectrum interferences that could complicate the identification
process, recognizing which ions are fragments and which are not,
becomesmandatory. From this point of view, UHPLC resolution
proved to be valuable for choosing perfectly coeluting ions (see
Fig. 5c). Irbesartan is an angiostensin II receptor antagonist used
in the treatment of hypertension that has been in the market for
over 10 years.46 Some fragments observed for irbesartan had been
previously reported by ion trap;46 the most used SRM transition
coincides with the most abundant fragment ion of the TOF
spectra (m/z 207.0922).47,48However, asMassFragment is a bond-
disconnecting software, correct justification is not always feasible.
Thus, for m/z 192 ion unreliable structures were suggested. In
these cases, previous analyst knowledge or better fragmentation
prediction software is necessary.
In Table 1, the strategy used for the identification of each
suspected positive is shown. Bibliographic search and fragment
interpretation were helpful to confirm potential positives. When
a disagreement occurred between experimental and literature
data for fragment ions (if available), and when structures
provided by MassFragment software did not fit with the struc-
ture of the candidate, the suspected positive could not be
confirmed, and no further research was performed for its
elucidation.a) Overlapped nw-XIC for two main ions (protonated ion at m/z 194 and
ns in the HE function. LE and HE spectra for sample (b) and reference
.
This journal is ª The Royal Society of Chemistry 2012
Pu
bl
ish
ed
 o
n 
28
 N
ov
em
be
r 2
01
1.
 D
ow
nl
oa
de
d 
on
 0
6/
06
/2
01
3 
13
:3
6:
17
. 
View Article OnlineFollowing the above mentioned strategies, high confidence in
the identification process can be achieved. However, no definitive
confirmation should be made without injecting the reference
standard. Thus, for the most frequently detected pharmaceuti-
cals, irbesartan, valsartan and gabapentin, the reference
compounds were acquired. After injecting the standard solu-
tions, all suspect positives in wastewater were confirmed. Our
experience on identification of suspect organic contaminants by
LC-QTOF under MSE mode is that the great majority of suspect
positives (around 95%) were subsequently confirmed when the
reference standard was acquired. This means that acquisition of
expensive standards could be made only when solid evidence
exists on their presence in samples analyzed. The decision on
which standards should be acquired would then be made on the
basis of previous findings by QTOF MS.
To overcome some post-target limitations and to enhance
detectability and identification reliability, improvements in the
database approach were made to minimize ‘‘missing’’ compounds
due to abundant adduct formation and/or in-source fragmentation.
More entries were added in the pollutant database for compounds
with a high degree of fragmentation and sodium adduct formation.
This is easier when information for the compound is available.
After reprocessing the samples using the new, enlarged database,
two more compounds (gemfibrozil and bezafibrate) were found inFig. 7 Non-target screening using experimental library search. Accurate-mass
the main deconvoluted ions of Fumonisin B1 under LE and HE conditions
standard (c). Library match (80%) and accurate-mass confirmation of the ion
This journal is ª The Royal Society of Chemistry 2012wastewater. These compounds were not detected before due to the
abundant sodium adduct formation in positive electrospray ion-
isation (marked as * in Table 1). In addition, not only the detection
step was improved but also the confidence in the identification, as
for several analytes, both the protonated molecule and in-source
fragments/sodium adducts were also detected (information shown
in Table 1). To exemplify this feature, Fig. 6 shows a positive
finding of MDMA in EWW. As can be seen, the protonated ion
and main in-source fragment ion of the compound were both
detected, the latter being muchmore abundant than the protonated
molecule.
As a summary, two situations could be considered when using
the post-target approach based on QTOF measurements:
(a) Detection of target analytes for which standard is available
and has been previously injected under the same conditions as the
samples. In this case, retention time, in-source fragmentation and
adduct formation became useful tools, making the confirmation
of findings highly reliable, surely unequivocal.
(b) Detection of suspect compounds for which reference stan-
dards are unavailable. Obviously, the situation requires extra-work
and time. After a careful study of the full-scan accurate mass data
obtained for the suspect compound, a reliable identification could
be advanced. A definitive confirmation by injection of the reference
standard would be required in the case that significantconfirmation of the mycotoxin fumonisin B1. (a) Overlapped nw-XICs of
. Mass spectrum at LE and HE functions for sample (b) and reference
s (mass errors below 1.3 mDa).
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View Article Onlineenvironmental or legal implications were associated to the presence
of the suspect compound. Here, the experience of the analyst and
their background on mass spectrometry is of the utmost relevance.
Regarding the non-target screening results, it must be noted
that the deconvolution process depends to a great extent on the
intensity of the chromatographic peak. Using this approach,
several contaminants were missed, as the number of compounds
found in the samples was considerably lower than using the
targeted one (Table 1). Furthermore, non-target screening with
empirical library allowed us to detect very few compounds, not
only because of the component detection limitations but also due
to fewer entries in this library (231). However, confirmation of
the identity becomes simultaneous and more reliable than with
other approaches (i.e. theoretical library) as LE and HE spectra
are compared with those included in the empirical library making
unlikely the reporting of false positives. As an example, Fig. 7
shows a corn sample positive to fumonisin. In this figure, two and
five coeluting ions were selected for component detection in the
LE and HE functions, respectively (Fig. 7a). Both deconvoluted
LE and HE mass spectra were automatically compared with
those of fumonisin B1 included in the empirical mass spectra
library with a match of 80% (Fig. 7b and c).
When employing the theoretical, library-based, non-target
screening approach, the investigation of findings when reference
standards were unavailable was carried out using the same two
strategies discussed before for post-target screening.
This work shows that the post-target approach has better
capability for wide-scope screening of different analyte/sample
matrix combinations. However, the non-target approach still has
some advantages, especially when using an experimental library,
as a comparison of the suspect compound versus library spectra is
automatically performed achieving a highly reliable identification.
In addition, other non-expected compounds that might be present
in samples at relatively high concentrations might be detected
without any kind of selection (pre- or post-target). However,
searching for unknowns is an analytical challenge, where the
possibilities to elucidate the components detected are rare.38 The
main limitation for this approach is the difficulty of having large
compound libraries similar to those used in GC-MS. At the
moment, spectral libraries for LC-MS are home-made and are
quite limited. Hopefully, in the near future large standardized
librarieswhichwill facilitate non-target screeningwill be available.
In this work, several contaminants have been found in the
three types of samples investigated. Some of them have been
tentatively identified without reference standard. The
compounds detected belong to very different chemical classes
and included emerging contaminants such as pharmaceuticals,
UV filters and drugs of abuse, as well as several pesticides.
Commonly used post-harvest fungicides imazalil and thia-
bendazol were identified in the orange and banana samples. In
the case of the corn samples, the mycotoxins Fumonisin B1 and
B2 were found, and also the less commonly detected Fumonisin
B3 and B4 that were not previously included in the common pre-
target approaches applied.Conclusions
The comparison of different strategies based on the use of
UHPLC coupled with QTOF MS for large-scale screening of208 | Anal. Methods, 2012, 4, 196–209organic pollutants in food, environmental and urine samples has
been carried out. Thanks to the accurate-mass, full-spectrum
acquisition in QTOF MS, it is feasible to apply both the target
and non-target approaches, which can be seen as complementary
within the public health field.
The application of the target approach to selected samples has
been demonstrated as an efficient tool for screening a large
number of pollutants. For this purpose, a database containing
information on the exact mass of the (de)protonated molecule
and on the fragment ions and adducts (typically sodium adducts)
has been created containing more than 1000 entries. This data-
base has been built on the basis of our own experience and from
data reported in the literature on LC-MS analysis of the
compounds. Once a compound is detected, the potential posi-
tives need to be confirmed taking into account the information
obtained on accurate masses of the (de)protonated molecule and
of fragment ions, as well as the isotopic distribution. This is
feasible using the MSE acquisition mode in the QTOF instru-
ment, which allows the simultaneous MS data acquisition at low
and high collision energy. The accomplishment of retention times
and experimental MSE fragmentation using reference standards
obviously facilitates the confirmation step.
In this work, an empirical library containing 231 selected
compounds has also been employed in both the target and non-
target approaches. Building empirical spectral libraries has been
found to be the best way to facilitate both screening types,
although it requires the injection of a large number of reference
standards to be efficiently applied.
The non-targeted screening presents important drawbacks at
low compound concentrations, especially in more complex-
matrix samples, due to the difficulties in the components detec-
tion step. Identification of non-target contaminants is greatly
facilitated when the compound detected is included in the home-
made libraries, otherwise the elucidation of the compound
becomes an analytical challenge where the possibilities of success
are rare.
An interesting advantage associated with TOF MS-based
methodologies concerns the possibility of performing retro-
spective analysis. This allows investigation of the presence of
organic contaminants that were included in the first screening.
This can be done at any time, without the need of either new
analysis or new sample injections.Acknowledgements
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